Media
Bod announces A$2 million capital raise as senior team takes pay cut
08 Nov 2023
Published by: Cannabiz
Bod Science plots another capital raise as expanded product range set to launch
01 Nov 2023
Published by: Cannabiz
dsm-firmenich PARTNERS WITH BOD SCIENCE TO ADVANCE SCIENCE BEHIND FIRST EVER CBD-BASED TREATMENT FOR INSOMNIA
18 Oct 2023
Published by: dsm-firmenich
Bod eyes opportunities beyond cannabis as Aqua Phase tech passes second bioavailability test
27 Sep 2023
Published by: Cannabiz
ASX Health Stocks: BOD says all trials are done, and it’s time to begin commercialising Aqua Phase
27 Sep 2023
Published by: Stockhead
Bod Unveils Initial Schedule 3 CBD Candidate Trial Results
08 Sep 2023
Published by: Hemp Gazette
BREAKING: Bod Science clinical trial ‘proves the efficacy of CBD’ for pharmacy sales
06 Sep 2023
Published by: Cannabiz
First on the ASX - BOD announces successful outcome for insomnia clinical trial
06 Sep 2023
Published by: Next Investors
BOD acquires CBD technology, insomnia trial results next two weeks
15 Aug 2023
Published by: Next Investors
